• Issue

    Thoracic Cancer: Volume 7, Issue 6

    625-693
    November 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 625-626
  • First Published: 02 November 2016

ORIGINAL ARTICLES

Open Access

Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer

Yi Zhang,  Kaijiong Zhang,  Zhenglian Luo,  Lian Liu,  Lichun Wu,  Jinbo Liu, 
  • Pages: 627-632
  • First Published: 01 August 2016
Open Access

Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung

Zhi Yang,  Zitong Wang,  Yong Duan,  Shaofa Xu, 
  • Pages: 633-638
  • First Published: 06 September 2016
Open Access

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response

Ha Young Park,  Hyung Joo Oh,  Ki-Hyun Kim,  Tae-Ok Kim,  Cheol-Kyu Park,  Hong-Jun Shin,  Jung-Hwan Lim,  Yong-Soo Kwon,  In-Jae Oh,  Yu-Il Kim,  Sung-Chul Lim,  Young-Chul Kim,  Yoo-Duk Choi, 
  • Pages: 639-647
  • First Published: 01 September 2016
Open Access

Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis

Qiuyi Zhang,  Xuchao Zhang,  Honghong Yan,  Benyuan Jiang,  Chongrui Xu,  Jinji Yang,  Zhihong Chen,  Jian Su,  Yi-Long Wu,  Qing Zhou, 
  • Pages: 648-654
  • First Published: 01 September 2016
Open Access

Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer

Hisao Imai,  Keita Mori,  Nodoka Watase,  Toshifumi Kazama,  Sakae Fujimoto,  Kyoichi Kaira,  Masanobu Yamada,  Koichi Minato, 
  • Pages: 655-662
  • First Published: 01 August 2016
Open Access

Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial

Yanzhe Zhu,  Yingying Du,  Hu Liu,  Tai Ma,  Yuanyuan Shen,  Yueyin Pan, 
  • Pages: 663-669
  • First Published: 24 August 2016
Open Access

Clinical outcome of node-negative oligometastatic non–small cell lung cancer

Kiyohiro Sakai,  Masayuki Takeda,  Hidetoshi Hayashi,  Kaoru Tanaka,  Takeshi Okuda,  Amami Kato,  Yasumasa Nishimura,  Tetsuya Mitsudomi,  Atsuko Koyama,  Kazuhiko Nakagawa, 
  • Pages: 670-675
  • First Published: 12 September 2016

CASE REPORTS

Open Access

Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare case

Kana Kataoka,  Eiji Osaka,  Tetsuo Shimizu,  Yuki Okamura,  Yukihiro Yoshida,  Yasuaki Tokuhashi, 
  • Pages: 676-680
  • First Published: 13 June 2016
Open Access

Complete remission of liver metastasis in a lung cancer patient with epidermal growth factor mutation achieved with Icotinib

Zhouyu Zhu,  Ying Chai, 
  • Pages: 681-683
  • First Published: 04 August 2016
Open Access

Diagnosis of a rare primary pulmonary synovial sarcoma with endobronchial ultrasound-guided transbronchial needle aspiration

Cai-hua Wang,  Chuan-cai Xu,  Jun-hong Jiang,  Yan-bin Chen,  Sheng-hua Zhan, 
  • Pages: 684-688
  • First Published: 10 September 2016

ACKNOWLEDGMENTS

Open Access

Acknowledgments

  • Pages: 689-693
  • First Published: 02 November 2016